Type 2 diabetes is associated with obesity and elevated plasma levels of free fatty acids (FFA) and triacylglycerides (TAG). Obesity is also associated with the development of insulin resistance in insulin-sensitive tissues that results in hyperglycemia and hyperinsulinemia. b-cell failure in obesity-associated type 2 diabetes is believed to correlate with the intracellular accumulation of lipids that contribute to defects in insulin secretion and/or insulin and growth factor signaling necessary to maintain sufficient b-ceIl mass. The overall goal of this proposal is to define the cellular mechanisms whereby FFA and TAG exert their inhibitory effects on b-cell function in obesity-associated type 2 diabetes. Our recent studies have identified lipoprotein lipase (LpL) in b-cells, a key enzyme for catalyzing the hydrolysis of lipoprotein-associated TAG, to produce FFA for local cellular uptake. Our overall hypothesis is that LpL serves as a gatekeeper for the physiological import of FFA into b-cells analogous to that described for adipocytes. Furthermore, our new findings indicate that elevated concentrations of glucose and insulin enhance LpL enzyme activity in b-cells that may explain how b-cells continue to accumulate lipids in the setting of hyperglycemia and hyperinsulinemia associated with type 2 diabetes.
In specific aim 1, we will: 1) further characterize the ability of nutrients, glucose and amino acids, and insulin to regulate LpL activity, expression and intracellular localization in rodent and human islets and b-cell lines, 2) assess the role of rapamycin, an inhibitor of mTOR, to regulate LpL and: lipid levels, and 3) evaluate LpL function in vivo.
In specific aim 2, we will 1) examine the effects of enhanced FFA uptake by overexpression of FATP1 and ACS1, 2) characterize lipid droplet associated proteins, ADRP, perilipins and HSL, and 3) determine the regulation of lipid droplet synthesis and breakdown by phosphorylation and overexpression of lipid droplet associated proteins. Mitochondria exert a major role in glucose-stimulated insulin secretion, and mitochondrial activation is required for normal signal transduction. Recent studies suggest that FFA up-regulate mitochondrial uncoupling proteins (UCP) proposed to dissipate the proton gradient across the mitochondrial inner membrane.
In specific aim 3, we will: 1) determine the role of UCP in mediating b-cell function by overexpressing UCP-2 in islets and b-cell lines, 2) assess the modulation of UCP-2 by increased levels of FFA in vitro and in vivo as described in specific aims 1 and 2. This experimental approach will be used to delineate the link between FFA and b-cell mitochondrial dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK006181-43
Application #
6851715
Study Section
Metabolism Study Section (MET)
Program Officer
Blondel, Olivier
Project Start
1977-05-01
Project End
2007-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
43
Fiscal Year
2005
Total Cost
$359,550
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Rohatgi, Nidhi; Aly, Haytham; Marshall, Connie A et al. (2013) Novel insulin sensitizer modulates nutrient sensing pathways and maintains ýý-cell phenotype in human islets. PLoS One 8:e62012
Aly, Haytham; Rohatgi, Nidhi; Marshall, Connie A et al. (2013) A novel strategy to increase the proliferative potential of adult human ?-cells while maintaining their differentiated phenotype. PLoS One 8:e66131
Vernier, Stephanie; Chiu, Angela; Schober, Joseph et al. (2012) ?-cell metabolic alterations under chronic nutrient overload in rat and human islets. Islets 4:379-92
Rohatgi, Nidhi; Remedi, Maria S; Kwon, Guim et al. (2010) Therapeutic Strategies to Increase Human ?-Cell Growth and Proliferation by Regulating mTOR and GSK-3/?-Catenin Pathways. Open Endocrinol J 4:
Liu, Hui; Remedi, Maria S; Pappan, Kirk L et al. (2009) Glycogen synthase kinase-3 and mammalian target of rapamycin pathways contribute to DNA synthesis, cell cycle progression, and proliferation in human islets. Diabetes 58:663-72
Kwon, Guim; Marshall, Connie A; Liu, Hui et al. (2006) Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets. J Biol Chem 281:3261-7
Pappan, Kirk L; Pan, Zhijun; Kwon, Guim et al. (2005) Pancreatic beta-cell lipoprotein lipase independently regulates islet glucose metabolism and normal insulin secretion. J Biol Chem 280:9023-9
Kwon, Guim; Pappan, Kirk L; Marshall, Connie A et al. (2004) cAMP Dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells. J Biol Chem 279:8938-45
Cruz, W S; Kwon, G; Marshall, C A et al. (2001) Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and beta-cell dysfunction. J Biol Chem 276:12162-8
Hill, J R; Kwon, G; Marshall, C A et al. (1998) Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. J Biol Chem 273:3308-13

Showing the most recent 10 out of 28 publications